Pages that link to "Q53247401"
Jump to navigation
Jump to search
The following pages link to Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. (Q53247401):
Displaying 31 items.
- SerpinB1 is critical for neutrophil survival through cell-autonomous inhibition of cathepsin G (Q28287865) (← links)
- Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma (Q33612801) (← links)
- Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type (Q33677463) (← links)
- Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets (Q34898306) (← links)
- Control of granzymes by serpins. (Q35011536) (← links)
- Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma. (Q36156508) (← links)
- Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type. (Q36358059) (← links)
- Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors (Q36823719) (← links)
- Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type (Q37108162) (← links)
- The role of serpins in vertebrate immunity (Q37170955) (← links)
- STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma (Q37485330) (← links)
- Extranodal NK / T-cell lymphoma, nasal type: new staging system and treatment strategies (Q37598368) (← links)
- Guidelines for the management of mature T‐cell and NK‐cell neoplasms (excluding cutaneous T‐cell lymphoma) (Q37863688) (← links)
- Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders (Q38179491) (← links)
- Management of patients with non-Hodgkin's lymphoma: focus on adoptive T-cell therapy (Q38912282) (← links)
- JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma. (Q39149556) (← links)
- Increased proteinase inhibitor-9 (PI-9) and reduced granzyme B in lung cancer: Mechanism for immune evasion? (Q39386456) (← links)
- MicroRNA-146a Downregulates NFκB Activity via Targeting TRAF6 and Functions as a Tumor Suppressor Having Strong Prognostic Implications in NK/T Cell Lymphoma (Q39536983) (← links)
- CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis (Q40984277) (← links)
- Extranodal Natural Killer/T-Cell Lymphoma in Children and Adolescents: A Report of 17 Cases in China (Q41014498) (← links)
- Diagnosis and treatment of a patient with primary gastric extranodal natural killer/T-cell lymphoma, nasal type (Q42881030) (← links)
- Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy (Q43254038) (← links)
- Skp2/p27 expression profile is correlated with Epstein-Barr virus status in extranodal nasal-type natural killer cell lymphoma (Q45394710) (← links)
- Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma. (Q45960706) (← links)
- Association between higher expression of YB-1 and poor prognosis in early-stage extranodal nasal-type natural killer/T-cell lymphoma. (Q53067126) (← links)
- IL-13 Contributes to Drug Resistance of NK/T-Cell Lymphoma Cells by Regulating ABCC4 (Q60956230) (← links)
- The extent of cutaneous lesions predicts outcome in extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract with secondary cutaneous involvement (Q82247407) (← links)
- Phase 2 trial of "sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma (Q82798869) (← links)
- Immunophenotypic characteristics and clinical relevance of CD56 and CD56− extranodal nasal-type natural killer/T-cell lymphoma (Q83416748) (← links)
- Radiotherapy Alone With Curative Intent in Patients With Stage I Extranodal Nasal-Type NK/T-Cell Lymphoma (Q83797250) (← links)
- Failure patterns and clinical implications in early stage nasal natural killer/T‐cell lymphoma treated with primary radiotherapy (Q83979517) (← links)